Corcept Therapeutics Inc (CORT): EPS (Diluted)
$0.82
Year ended 2025-12-31
-2.0%
3-year compound annual growth
-0.7%
5-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.82 | -33.3% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $1.23 | +30.9% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $0.94 | +8.0% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $0.87 | -2.2% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $0.89 | +4.7% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $0.85 | +10.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $0.77 | +28.3% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $0.60 | -42.3% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $1.04 | n/m | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $0.07 | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$0.06 | n/a | 2018-02-28, From 2015-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $0.82 | -33.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $0.93 | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.73 | -7.0% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $0.16 | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $2.03 | -33.7% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$0.68 | n/m |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | -$0.01 | n/m |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $0.75 | n/m |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$5.83 | n/m |
Compare CORT, EBS, COLL, PCRX side by side · Screen every company in Pharmaceutical Preparations ↗